Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Corium
Corium
(CORI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Adlarity
Donepezil
2022-03-11
2025-2038
Alzheimer disease
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Donepezil
alzheimer disease
,
dementia
Enoblituzumab
peripheral arterial disease
,
coronary artery disease
,
paralysis
,
vascular diseases
,
intermittent claudication
,
peripheral vascular diseases
,
atrial fibrillation
,
stroke
,
atrial flutter
,
cardiac arrhythmias
,
tachycardia
,
syncope
Microcrystalline cellulose
acne vulgaris
,
actinic keratosis
,
keratosis
,
cataract
,
postoperative complications
,
eye infections
,
uveitis
,
inflammation
,
conjunctivitis
,
allergic conjunctivitis
,
contact lenses
E2020
alzheimer disease
,
dementia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use